COMP <GO>
EPAC vs ACMR // ENTERPRISE SCALE & MARKET CAP
Enerpac Tool Group Corp. (NYSE) VS. ACM Research Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: EPAC 11
— ACMR 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ACMR
LAST: $43.45 (+7.13%) • MKT CAP: $2.08B
market-cap
$2.08B
LAST: $44.15 (-2.90%) • MKT CAP: $3.17B
market-cap
$3.17B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EPAC VS. ACMR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EPAC | ACMR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 50.50% | 44.40% | +6.10 | EPAC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 22.40% | 9.80% | +12.60 | EPAC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.4x | 18.2x | -2.80 | EPAC | /valuation <GO> |
| Free Cash Flow Yield | 5.52% | -1.94% | +7.46 | EPAC | /fcf-yield <GO> |
| Operating Margin | 21.60% | 12.10% | +9.50 | EPAC | /operating-margins <GO> |
| Net Profit Margin | 15.00% | 10.40% | +4.60 | EPAC | /net-margins <GO> |
| Revenue Growth (YoY) | 4.60% | 15.20% | -10.60 | ACMR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.11% | 0.00% | +0.11 | EPAC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.26 | 3.50 | +1.76 | EPAC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 5/9 | +4.00 | EPAC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.5 | 31.3 | +42.20 | EPAC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 30.7x | -10.50 | EPAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $2.08B | $3.17B | -$1.09B | ACMR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EPAC REV | ACMR REV | EPAC GROSS % | ACMR GROSS % | EPAC FCF | ACMR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $616.9M | $901.3M | 50.5% | 44.4% | $111.3M | -$66.6M |
| FY 2024 | $589.5M | $782.1M | 51.1% | 50.1% | $81.3M | $70.0M |
| FY 2023 | $598.2M | $557.7M | — | — | $77.6M | -$75.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EPAC // BETA —
ACMR // BETA —